A double-blinded evaluation of propacetamol versus ketorolac in combination with patient-controlled analgesia morphine: Analgesic efficacy and tolerability after gynecologic surgery
G. Varrassi et al., A double-blinded evaluation of propacetamol versus ketorolac in combination with patient-controlled analgesia morphine: Analgesic efficacy and tolerability after gynecologic surgery, ANESTH ANAL, 88(3), 1999, pp. 611-616
Citations number
29
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
We assessed the relative morphine consumption in a combined analgesic regim
en (on-demand morphine plus the nonopioids propacetamol or ketorolac) after
gynecologic surgery. Two hundred women randomly received two IV doses of p
ropacetamol 2 g or ketorolac 30 mg ina double-blinded, double-dummy trial.
Patients were monitored for 12 h, and the following efficacy variables were
assessed: total dose of morphine, pain intensity, and global efficacy. Saf
ety and tolerability were evaluated by the occurrence of adverse events, es
pecially the presence and intensity of gastrointestinal symptoms. Hemostati
c variables were measured 30 and 60 min after the first infusion; arterial
blood pressure, heart and respiratory rates, sedation scores, and renal and
hepatic function were also assessed. Total morphine requirements were not
significantly different between the propacetamol (10.6 +/- 4.8 mg) and keto
rolac (10.2 +/- 4.4 mg) groups. The evolution of pain intensity and the glo
bal efficacy also showed similar patterns in the two groups: 70.2% of patie
nts in the propacetamol group rated the efficacy as "good/excellent" compar
ed with 68.2% in the ketorolac group. There were no clinically significant
changes in vital signs or laboratory values and no observed differences bet
ween the two groups, although ketorolac slightly, but not significantly, pr
olonged the bleeding time. Epigastric pain was present in 9% and 15% of pat
ients receiving propacetamol and ketorolac, respectively. There were two ad
verse events in the propacetamol group and four in the ketorolac group. Pro
pacetamol demonstrates an efficacy similar to that of ketorolac and has an
excellent tolerability after gynecologic surgery. Implications: Propacetamo
l and ketorolac, combined with patient-controlled analgesia morphine, show
similar analgesic efficacy after gynecologic surgery. Morphine consumption
and pain scores were comparable in the two studied groups. Propacetamol is
as effective as ketorolac and has an excellent tolerability af ter gynecolo
gic surgery.